Accelrys Forms Partnership with Aquavit Pharma and 2 Stocks Enjoying 52-Week Highs

Accelrys (NASDAQ:ACCL): Aquavit Pharmaceuticals and Accelrys Software have formed an alliance in the development of Aquavit’s PITO-001 and MAV-403 products. This agreement was signed on September 12, 2012. Under the terms of the partnership, Aquavit will utilize the scientifically aware Accelrys Enterprise Platform to develop advanced medical software for cutting-edge personalized medicine. Their shares closed at $8.66, they were up $0.15 or 1.76% on the day. The firm has traded $5.68 to $8.55 in a 52 week range.

Chevron Corp. (NYSE:CVX):  Following the significant decline in oil production after the Deepwater Horizon disaster, the United States, Gulf of Mexico, is set for an energy boom.  According to the consulting firm Bentek, Energy Gulf oil flows will increase by about 28% to 1.8 million barrels per day by 2022. Chevron Corp.’s shares closed at $117.80, they are down $0.05 or 0.04% on the day. They have traded $86.68 to $118.50 in a 52 week range.

Darden Restaurants (NYSE:DRI):  Darden Restaurants affirmed their financial outlook for the fiscal year 2013, which includes the sales and earnings impact from their August 29 acquisition of Yard House. The Company continues to expect that combined United States, same restaurant sales growth, in the fiscal year 2013, for Red Lobster, Olive Garden and Long Horn Steakhouse will be approximately 1%-2%, and that they will open approximately 100 to 110 net, new restaurants in the fiscal year 2013, not including Yard House. In lieu of this, they continue to expect the total sales growth in 2013 to be between 9%-10% and they anticipate that diluted net earnings, per share growth, from continuing operations will be between 5%-9%. The expectation regarding diluted earnings per share includes acquisition related costs and purchase accounting adjustments of approximately 7c-10c. Their shares closed at $57.21, they were up $2.49 or 4.55% on the day. Darden Restaurants has traded $40.69 to $55.84 in a 52 week range.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>